Directory › Boston Analytical

Boston Analytical — Salem

Salem, New Hampshire, United States · Testing lab

This is a record of what regulators published, not a rating.

Site facts

Company
Boston Analytical
Name(s) in FDA data
Boston Analytical, Inc.
FEI number(s)
1221426 (present in FDA Data Dashboard records for this name and city)
Location (as in FDA data)
Salem, New Hampshire, United States 03079
Records matched
8 FDA inspections · 4 inspections with posted 483 citations
Most recent FDA inspection in dataset
07 Mar 2023 — NAI

Capabilities (from the company's website)

  • Analytical testing
    …Full-Service Analytical Testing Laboratory BA Sciences (BA) offers a complete range of analytical testing services to hel…
  • Medical device testing
    …ff, strong resources and the latest in technology. We provide biotech, pharmaceutical and medical device companies with: Over 30 years of experience Ability to handle complex projects The highes…

Taken from a company-level page; the company does not publish a separate page for this site, so tags may describe the wider organisation. Source: https://www.bostonanalytical.com/, checked 16 Oct 2026. Quoted text shows the wording each tag is based on.

Regulatory timeline

Newest first. Each entry links to the published source. Inspection classifications: NAI = no action indicated, VAI = voluntary action indicated, OAI = official action indicated (FDA definitions). Posted 483 citations are FDA's short summaries, not the full Form 483.

  1. 07 Mar 2023
    FDA inspection FDA inspection classified NAI

    No Action Indicated (NAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 1200703)

  2. 24 Jan 2020
    Form 483 observations 1 posted Form 483 citation(s)

    Citation summaries (1)
    • 21 CFR 211.165(c): Sampling and testing plans not followed

    Source: FDA Data Dashboard – Citations (FEI 1221426, inspection ID 1115784)

  3. 24 Jan 2020
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 1115784)

  4. 15 Jan 2019
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Veterinary. Project area(s): Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 1076790)

  5. 22 Sep 2016
    Form 483 observations 2 posted Form 483 citation(s)

    Citation summaries (2)
    • 21 CFR 211.166(a): Written program not followed
    • 21 CFR 211.194(a)(2): Laboratory Test Method Verification

    Source: FDA Data Dashboard – Citations (FEI 1221426, inspection ID 987020)

  6. 22 Sep 2016
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 987020)

  7. 23 Jun 2015
    Form 483 observations 4 posted Form 483 citation(s)

    Citation summaries (4)
    • 21 CFR 211.182: Personnel dating/signing equipment log
    • 21 CFR 211.194(b): Test method modification records do not include
    • 21 CFR 211.198(a): Complaint Handling Procedure
    • 21 CFR 211.67(b): Written procedures fail to include

    Source: FDA Data Dashboard – Citations (FEI 1221426, inspection ID 941530)

  8. 23 Jun 2015
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 941530)

  9. 09 Nov 2012
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 814115)

  10. 16 Jun 2011
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs. Project area(s): Drug Quality Assurance.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 730937)

  11. 23 Dec 2009
    Form 483 observations 5 posted Form 483 citation(s)

    Citation summaries (5)
    • 21 CFR 211.160(a): Following/documenting laboratory controls
    • 21 CFR 211.160(b)(4): Instruments, apparatus, et. al. not meeting specs
    • 21 CFR 211.165(f): Failing drug products not rejected
    • 21 CFR 211.194(a)(4): Complete Test Data
    • 21 CFR 211.194(e): Stability testing records not included

    Source: FDA Data Dashboard – Citations (FEI 1221426, inspection ID 635771)

  12. 23 Dec 2009
    FDA inspection FDA inspection classified VAI

    Voluntary Action Indicated (VAI). Product type(s): Drugs, Veterinary. Project area(s): Drug Quality Assurance; Monitoring of Marketed Animal Drugs, Feed, and Devices.

    Source: FDA Data Dashboard – Inspections (FEI 1221426, inspection ID 635771)

This is a record of what regulators published, not a rating. Absence of a record here does not mean no record exists; see methodology for what we check and how records are matched.